The positive patients to the Human Immunodeficiency Virus (HIV) with Highly Active Antiretroviral Therapy (HAART) present multiple alterations in their corporal composition and dyslipidemia, wich increase the cardiovascular risk. The investigators evaluated the efficiency of the combination of fish oil omega 3 fatty acids to different doses with the Therapeutic Lifestyle Changes (TLC) diet of the National Cholesterol Education Program on the profile of lipids and the corporal weight in patients with HIV treated with HAART.
Inclusion Criteria: * Patients positive to Human Immunodeficiency Virus or Acquired Immunodeficiency Syndrome * Patients older than 18 years positive to HIV/AIDS with HAART * Patients who agreed to sign consent under written information * Patients that had some type of dyslipidemia according the Mexican Norms of 2002. Exclusion Criteria: * Patient with mouth non-permeable * Patients with intolerance or allergy to fish oil * Patient record in the database SMART but inactive. * Patients who use or have used in the last 6 weeks food supplements that modify lipids. * Patient who have not attended two of the four set appointments for valuation.